This company has not started trading yet. The live 5-factor QL signal switches on automatically on its first session.
We are a company engaged in marketing, distributing, selling medicine product and providing relates services. Our medicine sales consist primarily of Traditional Chinese Medicines ("TCMD"), including those over the counter products ("OTC") for common illness with strong self-diagnosis and treatment attributes and tonics medicines for prevention and recuperation.
From HengHong Technology Inc.'s Form F-1/A filed with the SEC on 2026-09-02. The issuer's own words — QuantLogix does not paraphrase it.
The audited financial statements for this issuer are in its Form F-1/A filed 2026-09-02. QuantLogix only publishes figures it can read directly from the filing.
From HengHong Technology Inc.'s Form F-1/A filed with the SEC on 2026-09-02. Extraction is deterministic — the same filing always produces the same score; 623k characters of the document were scanned. Technology signals are lexical indicators, not a technical audit. Not investment advice; the debut itself will be this score's first grade.
Deal terms come from the public IPO calendar and change up to pricing — an expected date reads “to be announced” until the underwriters set it, and a range is not a final price. Implied market cap and float are arithmetic on those disclosed terms. Nothing on this page is a forecast or a recommendation.